Profile | GDS4284 / 201386_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 7043.04 | 95 |
GSM687648 | Patient 402 control | 5432.06 | 94 |
GSM687653 | Patient 403 control | 7005.24 | 95 |
GSM687658 | Patient 404 control | 4966.72 | 93 |
GSM687663 | Patient 411 control | 4996.39 | 93 |
GSM687668 | Patient 422 control | 6191.74 | 95 |
GSM687673 | Patient 424 control | 4666.13 | 93 |
GSM687678 | Patient 425 control | 5902.03 | 95 |
GSM687683 | Patient 427 control | 4018.2 | 92 |
GSM687688 | Patient 428 control | 4687.99 | 93 |
GSM687695 | Patient 441 control | 4573.58 | 93 |
GSM687699 | Patient 443 control | 5636.92 | 94 |
GSM687704 | Patient 444 control | 4927.69 | 93 |
GSM687707 | Patient 448 control | 6981.69 | 95 |
GSM687712 | Patient 449 control | 4920.53 | 93 |
GSM687719 | Patient 450 control | 5613.87 | 94 |
GSM687724 | Patient 451 control | 5978.7 | 95 |
GSM687728 | Patient 452 control | 5811.09 | 94 |
GSM687646 | Patient 401 treated 24h | 6072.85 | 95 |
GSM687649 | Patient 402 treated 24h | 6023.27 | 95 |
GSM687665 | Patient 411 treated 24h | 5255 | 94 |
GSM687651 | Patient 402 treated 4 weeks | 4502.6 | 93 |
GSM687667 | Patient 411 treated 4 weeks | 6434.07 | 95 |
GSM687670 | Patient 422 treated 24h | 5524.46 | 94 |
GSM687671 | Patient 422 treated 4 weeks | 7033.91 | 96 |
GSM687654 | Patient 403 treated 24h | 5757.97 | 94 |
GSM687675 | Patient 424 treated 24h | 5953.62 | 95 |
GSM687685 | Patient 427 treated 24h | 4207.48 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 7154.15 | 96 |
GSM687677 | Patient 424 treated 4 weeks | 3003.27 | 89 |
GSM687687 | Patient 427 treated 4 weeks | 5938.11 | 95 |
GSM687692 | Patient 428 treated 4h | 5429.51 | 94 |
GSM687716 | Patient 449 treated 4h | 4932.57 | 93 |
GSM687722 | Patient 450 treated 4h | 4840.86 | 93 |
GSM687680 | Patient 425 treated 24h | 5644.12 | 94 |
GSM687690 | Patient 428 treated 24h | 5200.14 | 93 |
GSM687700 | Patient 443 treated 24h | 3909.55 | 92 |
GSM687705 | Patient 444 treated 24h | 5186.08 | 93 |
GSM687714 | Patient 449 treated 24h | 5949.91 | 94 |
GSM687721 | Patient 450 treated 24h | 5538.32 | 94 |
GSM687682 | Patient 425 treated 4 weeks | 3260.65 | 89 |
GSM687694 | Patient 428 treated 4 weeks | 5316.6 | 94 |
GSM687702 | Patient 443 treated 4 weeks | 5124.09 | 94 |
GSM687718 | Patient 449 treated 4 weeks | 4387.34 | 92 |
GSM687723 | Patient 450 treated 4 weeks | 5722.5 | 94 |
GSM687661 | Patient 404 treated 4h | 5649.1 | 94 |
GSM687710 | Patient 448 treated 4h | 6540.61 | 95 |
GSM687726 | Patient 451 treated 4h | 6351.87 | 95 |
GSM687730 | Patient 452 treated 4h | 235.994 | 36 |
GSM687660 | Patient 404 treated 24h | 3688.43 | 91 |
GSM687697 | Patient 441 treated 24h | 3763.77 | 91 |
GSM687709 | Patient 448 treated 24h | 7163.17 | 96 |
GSM687725 | Patient 451 treated 24h | 6401.3 | 95 |
GSM687729 | Patient 452 treated 24h | 4280.31 | 92 |
GSM687727 | Patient 451 treated 4 weeks | 3983.76 | 92 |
GSM687731 | Patient 452 treated 4 weeks | 5536.66 | 94 |